tiprankstipranks
Company Announcements

Micro-X Ltd. Reschedules Investor Conference Call Amid Capital Raising Plans

Story Highlights
Micro-X Ltd. Reschedules Investor Conference Call Amid Capital Raising Plans

Discover the Best Stocks and Maximize Your Portfolio:

An update from Micro-X Ltd. ( (AU:MX1) ) is now available.

Micro-X Ltd., an industry leader in cold cathode x-ray technology, announced the rescheduling of its investor conference call originally set for February 5, 2025, due to ongoing preparations for a capital raising effort. The company plans to provide updated scheduling details soon. This development underscores Micro-X’s strategic financial initiatives to support its operations and growth in the health and security sectors, potentially impacting stakeholders by enhancing the company’s market position and operational capabilities.

More about Micro-X Ltd.

Micro-X Limited is an Australian hi-tech company specializing in cold cathode x-ray technology for the global health and security markets. They develop innovative x-ray products that are significantly smaller, lighter, and more power-efficient, enhancing mobility and usability in existing x-ray applications and creating new security solutions. Micro-X operates a vertically integrated design and production facility in Adelaide, Australia, and has an expanding presence in the US with a technical and commercial team based in Seattle. Their product portfolio includes mobile digital radiology solutions for healthcare, military, and veterinary use, as well as advanced security and diagnostic imaging technologies.

YTD Price Performance: -7.14%

Average Trading Volume: 465,691

Technical Sentiment Consensus Rating: Buy

Current Market Cap: A$45.53M

See more insights into MX1 stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1